No Need for Constant Help: Human IgG2 Antibodies Have an Autonomous Agonistic Activity for Immunotherapy of Cancer

被引：6

作者：

Lux, Anja ^{[1
]}

Nimmerjahn, Falk ^{[1
]}

机构：

[1] Univ Erlangen Nurnberg, Inst Genet, Dept Biol, D-91058 Erlangen, Germany

来源：

CANCER CELL | 2015年 / 27卷 / 01期

关键词：

GAMMA RECEPTOR ENGAGEMENT; FC; CELLS; CD40; RS;

D O I：

10.1016/j.ccell.2014.12.010

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：10 / 11

页数：2

共 11 条

[1] Cell Contact-Dependent Priming and Fc Interaction with CD32+ Immune Cells Contribute to the TGN1412-Triggered Cytokine Response [J].

Bartholomaeus, Patrick ;

Semmler, Linda Y. ;

Bukur, Thomas ;

Boisguerin, Valesca ;

Roemer, Paula S. ;

Tabares, Paula ;

Chuvpilo, Sergey ;

Tyrsin, Dmitry Y. ;

Matskevich, Alexey ;

Hengel, Hartmut ;

Castle, John ;

Unig, Thomas H. ;

Kalinke, Ulrich .

JOURNAL OF IMMUNOLOGY, 2014, 192 (05) :2091-2098

[2] Apoptotic and antitumor activity of death receptor antibodies require inhibitory Fcγ receptor engagement [J].

Li, Fubin ;

Ravetch, Jeffrey V. .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2012, 109 (27) :10966-10971

[3] Inhibitory Fcγ Receptor Engagement Drives Adjuvant and Anti-Tumor Activities of Agonistic CD40 Antibodies [J].

Li, Fubin ;

Ravetch, Jeffrey V. .

SCIENCE, 2011, 333 (6045) :1030-1034

[4] Impact of Immune Complex Size and Glycosylation on IgG Binding to Human FcγRs [J].

Lux, Anja ;

Yu, Xiaojie ;

Scanlan, Chris N. ;

Nimmerjahn, Falk .

JOURNAL OF IMMUNOLOGY, 2013, 190 (08) :4315-4323

[5] The TNFRs OX40, 4-1BB, and CD40 as targets for cancer immunotherapy [J].

Moran, Amy E. ;

Kovacsovics-Bankowski, Magdalena ;

Weinberg, Andrew D. .

CURRENT OPINION IN IMMUNOLOGY, 2013, 25 (02) :230-237

[6]

Nimmerjahn Falk, 2012, Cancer Immun, V12, P13

[7] Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti-CTLA-4 therapy against melanoma [J].

Simpson, Tyler R. ;

Li, Fubin ;

Montalvo-Ortiz, Welby ;

Sepulveda, Manuel A. ;

Bergerhoff, Katharina ;

Arce, Frederick ;

Roddie, Claire ;

Henry, Jake Y. ;

Yagita, Hideo ;

Wolchok, Jedd D. ;

Peggs, Karl S. ;

Ravetch, Jeffrey V. ;

Allison, James P. ;

Quezada, Sergio A. .

JOURNAL OF EXPERIMENTAL MEDICINE, 2013, 210 (09) :1695-1710

[8] Conformation of the Human Immunoglobulin G2 Hinge Imparts Superagonistic Properties to Immunostimulatory Anticancer Antibodies [J].

White, Ann L. ;

Chan, H. T. Claude ;

French, Ruth R. ;

Willoughby, Jane ;

Mockridge, C. Ian ;

Roghanian, Ali ;

Penfold, Christine A. ;

Booth, Steven G. ;

Dodhy, Ali ;

Polak, Marta E. ;

Potter, Elizabeth A. ;

Ardern-Jones, Michael R. ;

Verbeek, J. Sjef ;

Johnson, Peter W. M. ;

Al-Shamkhani, Aymen ;

Cragg, Mark S. ;

Beers, Stephen A. ;

Glennie, Martin J. .

CANCER CELL, 2015, 27 (01) :138-148

[9] Interaction with FcγRIIB Is Critical for the Agonistic Activity of Anti-CD40 Monoclonal Antibody [J].

White, Ann L. ;

Chan, H. T. Claude ;

Roghanian, Ali ;

French, Ruth R. ;

Mockridge, C. Ian ;

Tutt, Alison L. ;

Dixon, Sandra V. ;

Ajona, Daniel ;

Verbeek, J. Sjef ;

Al-Shamkhani, Aymen ;

Cragg, Mark S. ;

Beers, Stephen A. ;

Glennie, Martin J. .

JOURNAL OF IMMUNOLOGY, 2011, 187 (04) :1754-1763

[10] An Fcγ Receptor-Dependent Mechanism Drives Antibody-Mediated Target-Receptor Signaling in Cancer Cells [J].

Wilson, Nicholas S. ;

Yang, Becky ;

Yang, Annie ;

Loeser, Stefanie ;

Marsters, Scot ;

Lawrence, David ;

Li, Yun ;

Pitti, Robert ;

Totpal, Klara ;

Yee, Sharon ;

Ross, Sarajane ;

Vernes, Jean-Michel ;

Lu, Yanmei ;

Adams, Cam ;

Offringa, Rienk ;

Kelley, Bob ;

Hymowitz, Sarah ;

Daniel, Dylan ;

Meng, Gloria ;

Ashkenazi, Avi .

CANCER CELL, 2011, 19 (01) :101-113

← 1 2 →